Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803.

Asparagine-803 in the C-terminal transactivation domain of human hypoxia-inducible factor (HIF)-1 alpha-subunit is hydroxylated by factor inhibiting HIF-1 (FIH-1) under normoxic conditions causing abrogation of the HIF-1alpha/p300 interaction. NMR and other analyses of a hydroxylated HIF fragment produced in vitro demonstrate that hydroxylation occurs at the beta-carbon of Asn-803 and imply production of the threo -isomer, in contrast with other known aspartic acid/asparagine hydroxylases that produce the erythro -isomer.

[1]  Christopher J Schofield,et al.  Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.

[2]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[3]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[4]  H. Dyson,et al.  Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Livingston,et al.  Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[7]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[8]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[9]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[10]  P. Ratcliffe,et al.  Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.

[11]  S. White,et al.  HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[13]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[14]  A. Stern,et al.  Partial Purification and Characterization of Bovine Liver Aspartyl , & Hydroxylase * , 2001 .

[15]  Richard J. Lee,et al.  Asymmetric Synthesis of Orthogonally Protected l-threo-β-Hydroxyasparagine , 2000 .

[16]  E. Minet,et al.  A Model for the Complex Between the Hypoxia-Inducible Factor-1 (HIF-1) and its Consensus DNA Sequence , 1999, Journal of biomolecular structure & dynamics.

[17]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[18]  F. B. Charvillon,et al.  Synthesis of 3-Hydroxylated Analogues of D-Aspartic Acid β-Hydroxamate , 1997 .

[19]  J. Wands,et al.  Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. , 1996, The Journal of clinical investigation.

[20]  Jeremy N. S. Evans.  Biomolecular NMR Spectroscopy , 1995 .

[21]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Hanessian,et al.  Novel access to (3R)- and (3S)-3-hydroxy-L-aspartic acids, (4S)-4-hydroxy- L-glutamic acid, and related amino acids , 1993 .

[23]  J. Stenflo,et al.  Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. , 1991, Blood.

[24]  J. Stenflo,et al.  sup 1 H NMR assignment and secondary structure of the Ca sup 2+ -free form of the amino-terminal epidermal growth factor like domain in coagulation factor X , 1990 .

[25]  L. H. Huang,et al.  Hydroxylation of aspartic acid in domains homologous to the epidermal growth factor precursor is catalyzed by a 2-oxoglutarate-dependent dioxygenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Stern,et al.  Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. D. Collins,et al.  SPECIFIC CLEAVAGE OF PEPTIDES CONTAINING AN ASPARTIC ACID (β‐HYDROXAMIC ACID) RESIDUE , 1985 .

[28]  S. Hashiguchi,et al.  Synthesis of carumonam (AMA-1080) and a related compound starting from (2R,3R)-epoxysuccinic acid , 1985 .

[29]  P. G. Mattingly,et al.  CHIRAL SYNTHESIS OF PROTECTED 3-AMINO-4-(ALKOXYCARBONYL)-2-AZETIDINONES FROM β-HYDROXYASPARTIC ACID , 1984 .